NASDAQ · Medical - Care Facilities

DocGo Inc. (DCGO) Stock

$0.34 -0.15% NASDAQ: DCGO Healthcare

Valuation

MetricValue
Price$0.34
Market Cap$33.41M
P/E Ratio-0.19
P/B Ratio0.31
P/S Ratio0.12
EPS (TTM)$0.00
52-Week High$1.65
52-Week Low$0.31
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-115.58%
ROA-103.00%
ROCE-97.00%
Gross Margin-27.64%
Operating Margin-27.64%
Net Margin-65.29%
Debt/Equity0.22
Current Ratio2.27

Annual Financials (USD)

Metric20212022202320242025
Revenue$319.0M$441.0M$624.0M$617.0M$322.0M
Operating Profit$15.0M$22.0M$15.0M$29.0M$-89.0M
Net Profit$24.0M$35.0M$7.0M$20.0M$-182.0M
EPS$0.25$0.34$0.06$0.18$-1.84
Op Margin4.8%5.0%2.4%4.7%-27.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$310.0M$393.0M$490.0M$456.0M$217.0M
Total Liabilities$83.0M$114.0M$185.0M$140.0M$91.0M
Cash$176.0M$157.0M$59.0M$89.0M$51.0M
Borrowings$17.0M$20.0M$46.0M$57.0M$29.0M

Latest News

DocGo Launches Mobile Phlebotomy Services in South Florida Business Wire · Jun 3, 2026 How The DocGo (DCGO) Story Is Shifting As Transport Optimism Meets Lower Valuation Targets Simply Wall St. · May 16, 2026 DocGo Targets Profitability as It Pivots to Mobile Health, Medical Transport MarketBeat · May 16, 2026 US$1.87: That's What Analysts Think DocGo Inc. (NASDAQ:DCGO) Is Worth After Its Latest Results Simply Wall St. · May 14, 2026 DocGo Inc (DCGO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Operational Challenges GuruFocus.com · May 12, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$29.0M$-64.0M$70.0M$34.0M
Investing Cash Flow$-15.0M$-44.0M$-40.0M$-17.0M$-47.0M
Financing Cash Flow$-20.0M$-2.0M$-21.0M$-25.0M$-16.0M
Net Cash Flow$145.0M$-15.0M$-92.0M$35.0M$-55.0M
Free Cash Flow$-9.0M$23.0M$-74.0M$65.0M$27.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-0.24
FCF Yield-74.37%
Quick Ratio1.66
Interest Coverage-325.21
Return 1Y-52.24%
Return 3Y-92.80%
Return 5Y-93.29%

Ownership

Insiders Held3.07%
Institutions Held43.52%
Institutions Float Held44.90%
Institutional HolderSharesReport Date
Blackrock Inc.6,366,0282026-03-31
Vanguard Capital Management LLC3,682,5682026-03-31
P.A.W. Capital Corp3,000,0002026-03-31
Knott David M., Jr.2,670,8502026-03-31
Citadel Advisors Llc2,500,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
COYACoya Therapeutics, Inc. $4.95 -0.80% -4.53 $116.11M 0.00%
IMMXImmix Biopharma, Inc. $9.46 +1.83% -11.00 $514.64M 0.00%
MBOTMicrobot Medical Inc. $1.07 +0.00% -4.45 $48.76M 0.00%
MGNXMacroGenics, Inc. $3.74 +5.35% -16.25 $237.73M 0.00%
NSPRInspireMD Inc. $0.52 +8.54% -1.17 $24.40M 0.00%

About DocGo Inc.

DocGo Inc. is led by CEO Lee Bienstock, employs 3,404 people, headquartered in US, publicly traded since 2020.

DocGo Inc. (DCGO) stock trades at $0.34 with a market capitalization of $33.41M. The stock is valued at a price-to-earnings (P/E) ratio of -0.19, price-to-book of 0.31, price-to-sales of 0.12. Over the past 52 weeks the stock has ranged between $0.31 and $1.65, and currently trades 79.4% below its 52-week high.

On profitability, DocGo Inc. generates a return on equity (ROE) of -115.58%, return on capital employed of -97.00%, an operating margin of -27.64%, a net profit margin of -65.29%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides